Copyright
©The Author(s) 2016.
World J Clin Pediatr. Feb 8, 2016; 5(1): 95-101
Published online Feb 8, 2016. doi: 10.5409/wjcp.v5.i1.95
Published online Feb 8, 2016. doi: 10.5409/wjcp.v5.i1.95
Table 2 Patient evolutions after treatment n (%)
Evolution after treatment | Group A n = 14 | Group B Oral propranolol n = 9 | |||||
Oral corticosteroids | INF | Open surgical resection and endoscopic therapy | |||||
Single treatment n = 3 | Combined treatment n = 6 | Combined treatment n = 11 | Single treatment n = 5 | Combined treatment n = 6 | Single treatment n = 8 | Combined treatment n = 1 | |
Asymptomatic | 3 (100) | 0 (0) | 0 (0) | 2 (40) | 4 (66.6) | 8 (100) | 1 (100) |
Symptomatic | 0 (0) | 6 (100) | 1(100) | 3 (60) | 2 (33.3) | 0 (0) | 0 (0) |
Dysphonia | 0 (0) | 0 (0) | 0 (0) | 2 (40) | 1 (16.6) | 0 (0) | 0 (0) |
Stridor | 0 (0) | 5 (83.3) | 1 (100) | 1 (20) | 1 (16.6) | 0 (0) | 0 (0) |
Complications | 0 (0) | 3 (50) | 0 (0) | 1 (20) | 1 (16.6) | 0 (0) | 0 (0) |
Exitus | 0 (0) | 1 (16.6) | 0 (0) | 0 (0) | 1 (16.6) | 1 (12.5)2 | 0 (0) |
- Citation: Vivas-Colmenares GV, Fernandez-Pineda I, Lopez-Gutierrez JC, Fernandez-Hurtado MA, Garcia-Casillas MA, Matute de Cardenas JA. Analysis of the therapeutic evolution in the management of airway infantile hemangioma. World J Clin Pediatr 2016; 5(1): 95-101
- URL: https://www.wjgnet.com/2219-2808/full/v5/i1/95.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v5.i1.95